Di(2-Ethylhexyl) Phthalate Exposure during Cardiopulmonary Bypass

Di(2-ethylhexyl) phthalate is an excellent plasticizer for polyvinyl chloride but a known endocrine disrupting chemical. To investigate whether tubing containing no diethylhexyl phthalate reduces the overall extraction of this plasticizer during cardiopulmonary bypass, 16 patients undergoing coronary artery bypass grafting were randomly divided into 2 groups of 8 each. Group A had tubing containing diethylhexyl phthalate in the circuit, and group B had no diethylhexyl phthalate in the tubing. The plasma diethylhexyl phthalate level at the end of cardiopulmonary bypass was significantly increased compared to before anesthesia in both groups (group A: 103 ± 60 to 2,094 ± 1,046 ng·mL−1; group B: 135 ± 60 to 472 ± 141 ng·mL−1), and it was significantly higher in group A than group B. This study demonstrates that using tubing free from diethylhexyl phthalate significantly reduces the release of this agent during cardiopulmonary bypass, which may minimize exposure to diethylhexyl phthalate.

[1]  Yasuyuki Sasaki,et al.  Impact of non-di-(2-ethylhexyl)phthalate cardiopulmonary bypass tubes on inflammatory cytokines and coagulation-fibrinolysis systems during cardiopulmonary bypass , 2009, Journal of Artificial Organs.

[2]  H. Wendel,et al.  PVC-plasticizer DEHP in medical products: do thin coatings really reduce DEHP leaching into blood? , 2005, Perfusion.

[3]  Y. Alarie,et al.  Effects of mono-2-ethylhexyl phthalate on the respiratory tract in BALB/c mice , 2004, Human & experimental toxicology.

[4]  T. Gourlay,et al.  Inflammatory response of rat and human neutrophils exposed to di-(2-ethyl-hexyl)-phthalate-plasticized polyvinyl chloride. , 2003, Artificial organs.

[5]  R. Henderson,et al.  NTP Center for the Evaluation of Risks to Human Reproduction: phthalates expert panel report on the reproductive and developmental toxicity of di(2-ethylhexyl) phthalate. , 2002, Reproductive toxicology.

[6]  M. Luyckx,et al.  Comparative study of the leachability of di(2-ethylhexyl) phthalate and tri(2-ethylhexyl) trimellitate from haemodialysis tubing. , 2001, International journal of pharmaceutics.

[7]  M. Nakayama,et al.  [Extraction of di-2-ethylhexyl phthalate from a cardiopulmonary bypass circuit]. , 2001, Kyobu geka. The Japanese journal of thoracic surgery.

[8]  M. Dalgaard,et al.  The acute effects of mono(2-ethylhexyl)phthalate (MEHP) on testes of prepubertal Wistar rats. , 2001, Toxicology letters.

[9]  B. Lake,et al.  A cancer risk assessment of di(2-ethylhexyl)phthalate: application of the new U.S. EPA Risk Assessment Guidelines. , 1999, Regulatory toxicology and pharmacology : RTP.

[10]  R. Rubin,et al.  Extracorporeal membrane oxygenation exposes infants to the plasticizer, di(2-ethylhexyl)phthalate. , 1997, Critical care medicine.

[11]  P. Seth,et al.  Testicular toxicity of Di(2-ethylhexyl)phthalate in developing rats. , 1995, Veterinary and human toxicology.

[12]  M. Marinovich,et al.  Leachability of a new plasticizer tri-(2-ethylhexyl)-trimellitate from haemodialysis tubing. , 1988, The International journal of artificial organs.

[13]  J. F. Douglas,et al.  The carcinogenicity of dietary di(2-ethylhexyl) phthalate (DEHP) in Fischer 344 rats and B6C3F1 mice. , 1982, Journal of toxicology and environmental health.